Synthetic drug use rapidly rising in Europe, report finds

May 28, 2013

New synthetic psychoactive substances are making their way into Europe where the Internet is becoming a big challenge in the fight against illicit drugs, the continent's drug agency warned Tuesday.

Drug use in Europe remains high even though the consumption of cannabis and cocaine appears to be slowing, as is new heroin use, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) said in its annual report.

"New and patterns of use are appearing, both on the illicit drug market and in the context of non-controlled substances," the Lisbon-based centre said in its report.

"The Internet presents growing challenges, both as a mechanism for rapid diffusion of new trends and as a burgeoning anonymous marketplace with global reach."

The centre said more chemical or natural substances were emerging on the market, with 73 new detected in 2012—compared to just 49 in 2011—many of them close to cannabis due to high demand.

"A recent development is an increasing proportion of substances reported that are from less known and more obscure chemical groups," the report said.

"Many of the products on sale contain mixtures of substances, and the lack of pharmacological and toxicological data means it is hard to speculate on implications of use."

Mephedrone, a party drug often called "meow meow" described as a mix between amphetamines, cocaine and ecstasy, is an example of a new drug that has become a sought-after substance on the illicit stimulant market.

"Today's drug market appears to be... less structured around plant-based substances shipped over to consumer markets in Europe," the report said.

Altogether, around a quarter of Europe's has used an illicit drug at some point in their lives.

And while the practice of is slowing, the report says figures show the long-term decline in the number of new HIV diagnoses in Europe could be interrupted as a result of outbreaks among drug users in Greece and Romania.

The report however welcomed that a record number of people—an estimated 1.2 million—had received treatment for use in Europe during 2011.

Explore further: EU drugs watchdog warns of 'legal highs' surge

Related Stories

EU drugs watchdog warns of 'legal highs' surge

November 15, 2011
The rapid emergence of synthetic new drugs, often sold online as "legal highs," represents a significant challenge for policy makers in the coming decade, a European Union drugs agency said Tuesday.

Study to look at the impact of legal alternatives to illegal drugs

November 14, 2012
The use of legal substances that mimic the effects of illegal drugs appears to be on the rise in Australia, yet little is known about their long-term impact on users.

Alcohol causes a quarter of Europe road deaths

December 15, 2012
Alcohol abuse is responsible for around a quarter of the 30,000 people who die in road accidents across the European Union every year, the bloc's drugs agency said in a report published on Friday.

Illegal drug users more likely to use new synthetic drugs and pharmaceuticals

October 18, 2012
(Medical Xpress)—Methamphetamine users' use of synthetic cannabis products (such as Kronic) increased from ten per cent in 2010 to 41 per cent in 2011 an annual report on illegal drug use shows. Many of these synthetic ...

27 million problem drug users worldwide: UN

June 26, 2012
Some 27 million people worldwide are problem drug users, with almost one percent every year dying from narcotics abuse, while cannabis remains the most popular drug, a UN report showed Tuesday.

Recommended for you

Exercise helps treat addiction by altering brain's dopamine system

May 28, 2018
New research by the University at Buffalo Research Institute on Addictions has identified a key mechanism in how aerobic exercise can help impact the brain in ways that may support treatment—and even prevention strategies—for ...

Warning labels on alcohol containers highly deficient, new research shows

May 21, 2018
Current health warning labels on alcohol beverage containers in New Zealand are highly deficient, new research from the University of Otago, Wellington shows.

Serving smaller alcoholic drinks could reduce the U.K.'s alcohol consumption

May 14, 2018
New research published in Addiction, conducted by researchers from the Universities of Liverpool and Sheffield, highlights the potential benefits of reducing the standard serving size of alcoholic beverages.

Anti-alcoholism drug shows promise in animal models

May 3, 2018
Scientists at The University of Texas at Austin have successfully tested in animals a drug that, they say, may one day help block the withdrawal symptoms and cravings that incessantly coax people with alcoholism to drink. ...

FDA-approved drugs to treat diabetes and obesity may reduce cocaine relapse and help addicted people break the habit

April 28, 2018
Cocaine and other drugs of abuse hijack the natural reward circuits in the brain. In part, that's why it's so hard to quit using these substances. Moreover, relapse rates hover between 40 and 60 percent, similar to rates ...

Buprenorphine may be safer than methadone if treatment duration is longer, study suggests

April 20, 2018
The less commonly prescribed opioid substitute buprenorphine may be safer than methadone for problem opioid users, especially if used during the first month of treatment, according to a study which includes University of ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

arq
not rated yet May 28, 2013
This makes me wonder...why dont pharma companies step in with their own synthetic drugs. People want drugs for various reasons but drugs like these are dangerous. So pharma companies could enter this market and start making drugs like these but using safer ingredients that cause a high without hallucinations. Is it a stretch to think ingredients like that do exist? And of course well tested.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.